🔎 Trials Near Me

Hjem › Makuladegeneration › Texas › Dallas

Makuladegeneration kliniske forsøg i Dallas, TX

13 studier for Makuladegeneration søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

RekruttererFase 2/3
  • Texas Retina Associates, Dallas
Alder 50 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

RekruttererFase 2/3
  • Texas Retina Associates, Dallas
  • UT Southwestern Medical Center, Dallas
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

RekruttererFase 3
  • Retina Foundation of the Southwest, Dallas
  • Texas Retina Associates, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704

A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

RekruttererFase 1
  • Retina Foundation of Southwest, Dallas
Alder 6 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07734064

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

RekruttererFase 1
  • Retina Foundation of the Southwest, Dallas
Alder 50 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT03178149

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

RekruttererObservationsstudie
  • Retina Foundation of the Southwest, Dallas
Alder 55 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07144137

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

RekruttererObservationsstudie
  • Retina Foundation of the Southwest, Dallas
Alder 6 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07425574

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

RekruttererFase 1
  • Retina Foundation of the Southwest, Dallas
Alder 50 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07230834

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

RekruttererFase 1/2
  • Retina Foundation of the Southwest /ID# 262479, Dallas
Alder 50 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT07160179

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

RekruttererFase 3
  • Texas Retina Associate, Dallas
Alder 50 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT07064759

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Retina Foundation of the Southwest, Dallas
Alder 50 og opefter · Alle køn · Opdateret 27. mar. 2026 · NCT06924021

A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses

RekruttererFase 1Frivillige med god helbredstilstand velkomne
  • Dallas Clinical Research Unit, Dallas
Alder 18 til 50 · Alle køn · Opdateret 6. feb. 2026 · NCT07330674

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Retina of North Texas,, Dallas
Alder 18 og opefter · Alle køn · Opdateret 24. mar. 2025 · NCT06805474

Makuladegeneration forsøg i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.